Medicines Consent Notices




NEW ZEALAND GAZETTE, No. 10

1 FEBRUARY 2007


Product:
Active Ingredient:
Aripiprazole 30mg
Dosage Form:
Tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Company
Manufacturers:
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Otsuka Pharmaceutical Co Limited, Matsutani, Itano-cho, Itano-gun, Tokushima, Japan

Product:
Abilify
Active Ingredient:
Aripiprazole 5mg
Dosage Form:
Tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Company
Manufacturers:
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Otsuka Pharmaceutical Co Limited, Matsutani, Itano-cho, Itano-gun, Tokushima, Japan

Product:
Apidra 100IU/mL
Active Ingredient:
Insulin glulisine 3.49mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany

Product:
Aspen Ciprofloxacin
Active Ingredient:
Ciprofloxacin 2mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:
ACS Dobfar Info SA, Campascio, Switzerland

Product:
Cefuroxime Injection
Active Ingredient:
Cefuroxime sodium 1,577.8mg equivalent to cefuroxime 1,500mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer:
Sandoz GmbH, Kundl, Austria

Product:
Cefuroxime Injection
Active Ingredient:
Cefuroxime sodium 263mg equivalent to cefuroxime 250mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer:
Sandoz GmbH, Kundl, Austria

Product:
Cefuroxime Injection
Active Ingredient:
Cefuroxime sodium 788.9mg equivalent to cefuroxime 750mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer:
Sandoz GmbH, Kundl, Austria

Product:
SimStatin
Active Ingredient:
Simvastatin 80mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturers:
Rottendorf Pharma GmbH, Ennigerloh, Germany
Synthon Hispania SL, Poligno Las Salinas, Sant Boi de Llobregat, Barcelona, Spain

Product:
Symbicort Rapihaler
Active Ingredients:
Budesonide 80µg/dose
Formoterol fumarate 4.5µg/dose
Dosage Form:
Aerosol inhaler, metered dose
New Zealand Sponsor:
AstraZeneca Limited
Manufacturer:
AstraZeneca Dunkerque Production, Cedex, France

Product:
Symbicort Rapihaler
Active Ingredients:
Budesonide 160µg/dose
Formoterol fumarate 4.5µg/dose
Dosage Form:
Aerosol inhaler, metered dose
New Zealand Sponsor:
AstraZeneca Limited
Manufacturer:
AstraZeneca Dunkerque Production, Dunkerque Cedex, France

Dated this 26th day of January 2007.

MARK JACOBS, Acting Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2007, No 10


Gazette.govt.nz PDF NZ Gazette 2007, No 10





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines under Medicines Act 1981 (continued from previous page)

🏥 Health & Social Welfare
26 January 2007
Medicines, Distribution, Aripiprazole, Abilify, Bristol-Myers Squibb, Otsuka Pharmaceutical, Apidra, Insulin glulisine, sanofi-aventis, Aspen Ciprofloxacin, Pharmacy Retailing, Healthcare Logistics, Cefuroxime, Novartis, Sandoz, SimStatin, AFT Pharmaceuticals, Symbicort Rapihaler, AstraZeneca
  • MARK JACOBS, Acting Director-General, Public Health